10% SERIES A CONVERTIBLE NOTES
This Allonge (the "Allonge"), dated as of March 5, 2007, attached to and forming a part of certain 10% Series A
Convertible Promissory Notes, dated in November and December, 2005 (collectively, the "Note"), made by
AETHLON MEDICAL, INC., a Nevada corporation (the "Company"), payable to the order of Christian J.
Hoffman III (the "Holder"), in the total principal amount of $10,000.
1. Paragraph 1, "Interest," is hereby amended and restated in its entirety as follows:
1.1 This Note shall bear interest ("Interest") equal to ten percent (10%) per annum on the unpaid principal
balance, computed on a three hundred sixty (360)-day year, during the term of the Note. Interest will accrue on
each Advance commencing on the date of the Advance, as set forth on Exhibit A to this Note. The Company
shall pay all accrued Interest after the date of the Allonge on a quarterly basis on the first day of April, July,
October and on the Maturity Date. In no event shall the rate of Interest payable on this Note exceed the
maximum rate of Interest permitted to be charged under applicable law.
1.2 Within five (5) business days of the execution date of this Allonge, the Company will pay accrued Interest
through February 15, 2007. The Company will pay the Interest in units (the "Units") at the rate of $.20 per Unit
(the "Interest Payment Rate"). Each Unit is composed of one share of the Company's Common Stock and one
Class A Common Stock Purchase Warrant (the "Class A Warrant"). The Company will pay the accrued Interest
through February 15, 2007 by issuing 5,861 Units and will pay all accrued Interest thereafter in Units at the
Interest Payment Rate. Each Class A Warrant will be exercisable to purchase one share of Common Stock at a
price of $.20 per share (the Exercise Price"). If the Holder exercises Class A Warrants on or before July 3,
2008, the Company will issue the Holder one Class B Common Stock Purchase Warrant (the "Class B